Carlos Alban

AbbVie

Vice Chairman, Chief Commercial Officer

Overview

Carlos Alban received an average compensation of $7,675,582 at AbbVie from 2011 to 2018.

Annual data

2018

In 2018, Carlos Alban earned a total compensation of $8,983,079 as Vice Chairman, Chief Commercial Officer at AbbVie.

Ranking546 out of 8,301
Percentile93.4%

Carlos Alban's 2018 compensation ranked 546th out of 8,301 executive pay records tracked by us this year.

Carlos Alban earned more than 93.4% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking16 out of 420
Percentile96.2%

In the industry of pharmaceutical preparations, Carlos Alban's 2018 pay ranked 16th, among 420 executive pay records.

Carlos Alban earned more than 96.2% of executives in this industry.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$821,930
Non-Equity Incentive Plan$1,836,219
Option Awards$961,216
Salary$1,016,526
Stock Awards$4,005,388
Other$341,800
Total$8,983,079

Alban received $4,005,388 in stock awards, which accounts for 44.59% of total compensation.

Alban also received $821,930 of change in pension value and nonqualified deferred compensation earnings, $1,836,219 in non-equity incentive plan, $961,216 in option awards, $1,016,526 in salary and $341,800 in other compensation.

Carlos Alban's Pay$8,983,079
Median Employee's Pay$148,823
Pay Ratio60 : 1

For fiscal year 2018, the annual total compensation for Carlos Alban was $8,983,079 and for the median employee at AbbVie was $148,823. The resulting ratio of Carlos Alban's pay to the pay of median employee was 60 to one.

2017

In 2017, Carlos Alban earned a total compensation of $12,334,988 as Executive Vice President, Global Commercial Operations at AbbVie.

Ranking391 out of 13,165
Percentile97.0%

Carlos Alban's 2017 compensation ranked 391st out of 13,165 executive pay records tracked by us this year.

Carlos Alban earned more than 97.0% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking16 out of 1,094
Percentile98.5%

In the industry of pharmaceutical preparations, Carlos Alban's 2017 pay ranked 16th, among 1,094 executive pay records.

Carlos Alban earned more than 98.5% of executives in this industry.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$4,832,949
Non-Equity Incentive Plan$1,836,219
Option Awards$938,350
Salary$947,469
Stock Awards$3,522,250
Other$257,751
Total$12,334,988

Alban received $4,832,949 of change in pension value and nonqualified deferred compensation earnings, which accounts for 39.18% of total compensation.

Alban also received $1,836,219 in non-equity incentive plan, $938,350 in option awards, $947,469 in salary, $3,522,250 in stock awards and $257,751 in other compensation.

2016

In 2016, Carlos Alban earned a total compensation of $8,216,918 as Executive Vice President, Global Commercial Operations at AbbVie.

Ranking723 out of 13,853
Percentile94.8%

Carlos Alban's 2016 compensation ranked 723rd out of 13,853 executive pay records tracked by us this year.

Carlos Alban earned more than 94.8% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking27 out of 1,120
Percentile97.6%

In the industry of pharmaceutical preparations, Carlos Alban's 2016 pay ranked 27th, among 1,120 executive pay records.

Carlos Alban earned more than 97.6% of executives in this industry.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,884,312
Non-Equity Incentive Plan$1,510,000
Option Awards$738,798
Salary$920,077
Stock Awards$2,916,922
Other$246,809
Total$8,216,918

Alban received $2,916,922 in stock awards, which accounts for 35.50% of total compensation.

Alban also received $1,884,312 of change in pension value and nonqualified deferred compensation earnings, $1,510,000 in non-equity incentive plan, $738,798 in option awards, $920,077 in salary and $246,809 in other compensation.

2015

In 2015, Carlos Alban earned a total compensation of $7,049,639 as Executive Vice President, Commercial Operations at AbbVie.

Ranking963 out of 13,574
Percentile92.9%

Carlos Alban's 2015 compensation ranked 963rd out of 13,574 executive pay records tracked by us this year.

Carlos Alban earned more than 92.9% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking73 out of 1,144
Percentile93.6%

In the industry of pharmaceutical preparations, Carlos Alban's 2015 pay ranked 73rd, among 1,144 executive pay records.

Carlos Alban earned more than 93.6% of executives in this industry.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$696,390
Non-Equity Incentive Plan$1,200,000
Option Awards$1,015,522
Salary$888,461
Stock Awards$3,036,257
Other$213,009
Total$7,049,639

Alban received $3,036,257 in stock awards, which accounts for 43.07% of total compensation.

Alban also received $696,390 of change in pension value and nonqualified deferred compensation earnings, $1,200,000 in non-equity incentive plan, $1,015,522 in option awards, $888,461 in salary and $213,009 in other compensation.

2014

In 2014, Carlos Alban earned a total compensation of $9,262,861 as Executive Vice President, Commercial Operations at AbbVie.

Ranking590 out of 12,876
Percentile95.4%

Carlos Alban's 2014 compensation ranked 590th out of 12,876 executive pay records tracked by us this year.

Carlos Alban earned more than 95.4% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking47 out of 1,003
Percentile95.3%

In the industry of pharmaceutical preparations, Carlos Alban's 2014 pay ranked 47th, among 1,003 executive pay records.

Carlos Alban earned more than 95.3% of executives in this industry.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$2,297,655
Non-Equity Incentive Plan$1,300,000
Option Awards$801,145
Salary$844,461
Stock Awards$2,430,109
Other$1,589,491
Total$9,262,861

Alban received $2,430,109 in stock awards, which accounts for 26.23% of total compensation.

Alban also received $2,297,655 of change in pension value and nonqualified deferred compensation earnings, $1,300,000 in non-equity incentive plan, $801,145 in option awards, $844,461 in salary and $1,589,491 in other compensation.

2013

In 2013, Carlos Alban earned a total compensation of $5,135,169 as Executive Vice President, Commercial Operations at AbbVie.

Ranking1,216 out of 11,965
Percentile89.8%

Carlos Alban's 2013 compensation ranked 1,216th out of 11,965 executive pay records tracked by us this year.

Carlos Alban earned more than 89.8% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking60 out of 844
Percentile92.9%

In the industry of pharmaceutical preparations, Carlos Alban's 2013 pay ranked 60th, among 844 executive pay records.

Carlos Alban earned more than 92.9% of executives in this industry.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$416,924
Non-Equity Incentive Plan$1,030,000
Option Awards$795,752
Salary$710,000
Stock Awards$2,034,396
Other$148,097
Total$5,135,169

Alban received $2,034,396 in stock awards, which accounts for 39.62% of total compensation.

Alban also received $416,924 of change in pension value and nonqualified deferred compensation earnings, $1,030,000 in non-equity incentive plan, $795,752 in option awards, $710,000 in salary and $148,097 in other compensation.

2012

In 2012, Carlos Alban earned a total compensation of $6,529,670 as Executive Vice President, Commercial Operations at AbbVie.

Ranking834 out of 10,949
Percentile92.4%

Carlos Alban's 2012 compensation ranked 834th out of 10,949 executive pay records tracked by us this year.

Carlos Alban earned more than 92.4% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking33 out of 644
Percentile94.9%

In the industry of pharmaceutical preparations, Carlos Alban's 2012 pay ranked 33rd, among 644 executive pay records.

Carlos Alban earned more than 94.9% of executives in this industry.

Bonus$300,000
Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,801,009
Non-Equity Incentive Plan$675,000
Option Awards$331,473
Salary$615,769
Stock Awards$2,702,141
Other$104,278
Total$6,529,670

Alban received $2,702,141 in stock awards, which accounts for 41.38% of total compensation.

Alban also received $300,000 in bonus, $1,801,009 of change in pension value and nonqualified deferred compensation earnings, $675,000 in non-equity incentive plan, $331,473 in option awards, $615,769 in salary and $104,278 in other compensation.

2011

In 2011, Carlos Alban earned a total compensation of $3,892,335 as Executive Vice President, Commercial Operations at AbbVie.

Ranking1,454 out of 10,035
Percentile85.5%

Carlos Alban's 2011 compensation ranked 1,454th out of 10,035 executive pay records tracked by us this year.

Carlos Alban earned more than 85.5% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking57 out of 515
Percentile88.9%

In the industry of pharmaceutical preparations, Carlos Alban's 2011 pay ranked 57th, among 515 executive pay records.

Carlos Alban earned more than 88.9% of executives in this industry.

Change in Pension Value and Nonqualified Deferred Compensation Earnings$774,355
Non-Equity Incentive Plan$610,000
Option Awards$285,334
Salary$602,471
Stock Awards$1,514,013
Other$106,162
Total$3,892,335

Alban received $1,514,013 in stock awards, which accounts for 38.90% of total compensation.

Alban also received $774,355 of change in pension value and nonqualified deferred compensation earnings, $610,000 in non-equity incentive plan, $285,334 in option awards, $602,471 in salary and $106,162 in other compensation.